Company

Synnovation Therapeutics, Inc.

Synnovation Therapeutics develops small-molecule therapies for cancer.

About

Founded in 2021 and based in Delaware, Synnovation Therapeutics is a biotechnology company focused on precision oncology. It develops small-molecule therapies targeting specific cancer-driving mechanisms. The company raised USD 15 million in Series A funding in December 2023, led by Third Rock Ventures, with Lilly Asia Ventures, Nextech, Sirona Capital, Cormorant Asset Management and other investors participating.

1Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in